Need a specific person's email?
Browse Immunovant's employee directory (about 279 employees) and reveal verified emails free.
Immunovant's most common email format is First.Last@immunovant.com (ex. John.Doe@immunovant.com), used for 91% of immunovant.com addresses. Immunovant uses 3 email patterns.
| Format | Example | Share of immunovant.com |
|---|---|---|
| First.Last@immunovant.comMost common | John.Doe@immunovant.com | |
| Last.First@immunovant.com | Doe.John@immunovant.com | |
| First.Middle@immunovant.com | John.Michael@immunovant.com |
Browse Immunovant's employee directory (about 279 employees) and reveal verified emails free.
Biotechnology ResearchNew York, United States201-500 Employees
Immunovant is a clinical-stage biotechnology company focused on immunology, developing targeted therapies for autoimmune diseases. Its work centers on anti-FcRn technology designed to address the diverse needs of patients with autoimmune conditions. Based in New York, it operates within the biotechnology research sector and maintains a mid-sized team. Recent Phase 2 data for IMVT-1402 in difficult-to-treat rheumatoid arthritis report ACR20/50/70 response rates of 72.7%, 54.5%, and 35.8%. The results suggest potential for IMVT-1402 across autoimmune diseases and support the company's development efforts in this area. More information about Immunovant is available at immunovant.com.
Most common format
First.Last@immunovant.com
Example: John.Doe@immunovant.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.